These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2839198)
1. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. Terashita Z; Stahl GL; Lefer AM Biochem Pharmacol; 1988 Jul; 37(13):2659-65. PubMed ID: 2839198 [TBL] [Abstract][Full Text] [Related]
2. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart. Hu WM; Man RY Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604 [TBL] [Abstract][Full Text] [Related]
3. Effects of PAF on cardiac function and eicosanoid release in the isolated perfused rat heart: comparison between normotensive and spontaneously hypertensive rats. Giessler C; Pönicke K; Steinborn C; Brodde OE Basic Res Cardiol; 1995; 90(4):337-47. PubMed ID: 8534259 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart. Stahl GL; Lefer AM Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906 [TBL] [Abstract][Full Text] [Related]
5. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat. Bellan JA; Minkes RK; Hood JS; McMahon TJ; Higuera TR; Nossaman BD; McNamara DB; Kadowitz PJ Am J Physiol; 1992 Jul; 263(1 Pt 2):H234-43. PubMed ID: 1379004 [TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086. Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure. Graf BM; Fischer B; Martin E; Bosnjak ZJ; Stowe DF J Cardiovasc Pharmacol; 1997 Jan; 29(1):1-7. PubMed ID: 9007663 [TBL] [Abstract][Full Text] [Related]
9. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties. Man RY; Kinnaird AA Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Hu W; Kinnaird AA; Man RY Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung. Seale JP; Nourshargh S; Hellewell PG; Williams TJ Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart. Hu WM; Choy PC; Man RY Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890 [TBL] [Abstract][Full Text] [Related]
14. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Hu W; McNicholl IK; Choy PC; Man RY Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep. Ogletree ML; Brigham KL Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148 [TBL] [Abstract][Full Text] [Related]
16. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Piper PJ; Stewart AG Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369 [TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Teixeira MM; Williams TJ; Hellewell PG Br J Pharmacol; 1993 Dec; 110(4):1515-21. PubMed ID: 8306095 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 and nitroglycerin effects on canine epicardial conductance and distal coronary resistance vessels. Miller WL; Bove AA J Cardiovasc Pharmacol; 1989 Aug; 14(2):260-7. PubMed ID: 2476600 [TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation. Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884 [TBL] [Abstract][Full Text] [Related]
20. Effects of platelet-activating factor on myocardial contraction and myocardial relaxation of isolated perfused guinea pig hearts. Felix SB; Baumann G; Ahmad Z; Hashemi T; Niemczyk M; Berdel WE J Cardiovasc Pharmacol; 1990 Nov; 16(5):750-6. PubMed ID: 1703596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]